Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sumitomo Chemical among 4 stocks that closed crossing below VWAP
Four Nifty500 stocks, Zydus Wellness, Sumitomo Chemical India, Max Healthcare Institute, and Zensar Technologies, closed over 1.5% below their VWAP on July 6, indicating potential bearish momentum and increased selling pressure, according to technical scan data.
True North cashes out $2 billion for investors as PE firms step up exits
This comes on the back of exits for True North from portfolio firms like FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness and Home First Finance.
Market Trading Guide: Finolex Cables among 2 stock recommendations for Tuesday
Domestic equities closed higher on positive Asian cues, falling crude oil prices and hopes of an India-US trade deal. Analysts recommend buying Finolex Cables and Zydus Wellness, citing bullish technical setups, strong moving-average support and breakout patterns with upside potential.
Volumes spurt at Zydus Wellness Ltd counter
Zydus Wellness Ltd registered volume of 97.06 lakh shares by 14:14 IST on NSE, a 20.19 fold spurt over two-week average daily volume of 4.81 lakh shares
Hexaware Technologies, Zydus Wellness, ABDL, Go Digit shares rise amid heavy volumes - Upstox
Hexaware Technologies, Zydus Wellness, ABDL, Go Digit shares rise amid heavy volumesUpstox
Zydus Wellness Ltd leads gainers in 'A' group
Premier Explosives Ltd, Hexaware Technologies Ltd, AvenuesAI Ltd and Thangamayil Jewellery Ltd are among the other gainers in the BSE's 'A' group today, 29 June 2026.
Zydus Lifesciences share price jumps over 6% after Q4 results. Should you buy or sell?
Zydus Lifesciences shares rose over 6% after strong Q4FY26 earnings, reporting a 14.6% increase in net profit to ₹1,592.9 crore. Revenue grew to ₹7,587 crore, driven by the consumer wellness segment. The board approved a ₹1,100 crore share buyback and a Re 1 dividend.
Zydus Wellness sees more of price-led growth as costs surge
Rising input costs and acquisition-led expansion are reshaping the growth strategy at Zydus Wellness. Rising inflation may push it to rely more on price-led growth, signalling broader pressure on consumer-facing firms as the impact of the West Asia war spreads across the economy.
Zydus Wellness Target Price Raised By Motilal Oswal After Q4 Results — Check Potential Upside, Key Triggers
Zydus Wellness' recent initiatives around RiteBite and CC are trending at an exciting pace, both in terms of revenue and operating margin.
Zydus Wellness Q4 Result: Revenue jumps 63% on acquisitions; margin contracts
Zydus Wellness' fourth quarter profit fell 5.8% to ₹162 crore even as its revenue surged 62.6%, driven by acquisitions and strong growth in its Sugar Free, Glucon-D and Everyuth brands.
Indian Oil, JSW Cement, Zydus Wellness, Ola Electric Q4 Results Today — Earning Estimates
JSW Cement is expected to report March-quarter earnings with revenue at Rs 1,869.19 crore.
Mint Interview | Ignore the noise, focus on consumers, says Zydus Wellness CEO amidst stock rally
Shares of the company have jumped 25% in the last month despite posting losses in the last two quarters but its CEO Tarun Arora is nonchalant about it — instead is focused on staying ahead of consumer expectations. In this interview, Arora talks of his outlook for the company and new businesses.